BMC Research Notes (Jun 2017)

Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia

  • Eiman Agabain,
  • Hameed Mohamed,
  • Anas E. Elsheikh,
  • Hamdan Z. Hamdan,
  • Ishag Adam

Journal volume & issue
Vol. 10, no. 1
pp. 1 – 4


Read online

Abstract Objectives A case–control study was conducted at Omdurman Maternity Tertiary Hospital, Sudan, during the period from May to August 2014 to investigate AMH level in women with preeclampsia compared to healthy controls. The cases were women with preeclampsia and healthy pregnant women were the controls. The obstetrics and medical history was gathered using a questionnaire. AMH level was measured using ELISA. Results There was no significant difference between the two groups (40 in each arm of the study) in the age, parity and gestational age. Thirty-three of the 40 cases were patients with severe preeclampsia. There was no significant difference in median inter-quartile of the AMH level between the women with preeclampsia and the controls [0.700 (0.225–1.500) vs. 0.700 (0.400–1.275) ng/ml, P = 0.967]. In a linear regression model there was no association between the log of AMH and age, parity, gestational age, BMI, hemoglobin level and preeclampsia.